Scinai Immunotherapeutics Ltd. (SCNI:NASDAQ) closed at $0.542 on October 26, 2026, down 4.07% on the day. The stock trades 96.5% below its 52-week high of $15.50 and 4.6% above its 52-week low of $0.518. Over the past year, it lost 63.0%. Scinai Immunotherapeutics Ltd. is part of the Health Care sector.
In 252 trading sessions since October 24, 2025, SCNI closed higher on 100 days (40%). Its best day was February 23, 2026 (+913.89%) and its worst was September 15, 2026 (-36.89%). The stock moved 10% or more in a single session 28 times. It opened at least 5% above the previous day's high 7 times.
BiondVax Pharmaceuticals Ltd is engaged in the healthcare sector. Its main activity is the commercialization and manufacturing of flu vaccine. Its product is designed to provide multi-season and multi-strain protection against some human influenza virus strains, including both seasonal and pandemic flu strains. The company recently concluded two Phase I/II trials in which the multimeric-001 universal flu vaccine was shown to be safe and immunogenic.
Find more stocks like SCNI with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.